The teams of CNRS, FFIS - IMIB, SMS, and Mercurna came together to discuss the latest advancements and future directions in the NANEMIAR project. The picturesque setting of Île de Porquerolles (France) provides the perfect backdrop for inspiring discussions and collaborative A big thank you to Christophe Lachaud and team for putting together this e...
News & Events
People with congenital anemia do not produce red blood cells normally, which often leads to anemia (low red blood cell count) and excess iron in the body. There are different types of congenital anemia and all of them are characterized by a deficiency in the production of functional red blood cells that, unfortunately, cannot be treated with iron s...
Dr. Jenny van Asbeck, CEO at Mercurna who is a beneficiary of the NANEMIAR Project, explains to us how her team is contributing to NANEMIAR. Hi, Jenny! Thank you very much for accepting our invitation to this interview. First, could you explain the role of your team in NANEMIAR? Mercurna is one of the project partners in NANEMIAR. As a biotech star...
The LXVI National Congress of the Spanish Association of Hematology and Hemotherapy (SEHH) and the XL Congress of the Spanish Society of Thrombosis and Hemostasis (SETH), will take place jointly on October 24-26 in Palma de Mallorca, Spain. Two Congresses characterized by innovation, during three days full of science and training, without forgettin...
Our partner from CNRS attended the MARMARA Day for Entrepreneurship and Valorization (July 4, 2024), where Dr. Christophe Lachaud was invited to present the NANEMIAR project. This project is based on a collaboration with industry and aims to bridge the gap between research and practical applications. The event provided an excellent platform to show...